Targeting small airways in asthma: Improvement in clinical benefit?

Clinical Respiratory Journal

Volumn 5, Issue 3, 2011, Pages 125-130

  Ulrik, Charlotte Suppli ^a   Lange, Peter ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Airway inflammation; Asthma; Small airways; Ultrafine aerosols

Indexed keywords

BECLOMETASONE DIPROPIONATE; CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON;

AEROSOL; AIRWAY REMODELING; ASTHMA; CONTROLLED STUDY; HUMAN; LUNG DEPOSIT; LUNG FUNCTION; PRIORITY JOURNAL; REVIEW; SMALL AIRWAY DISEASE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AEROSOLS; AIRWAY OBSTRUCTION; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; BRONCHIOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFLAMMATION; LUNG; PARTICLE SIZE; PULMONARY VENTILATION; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 79959366396     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2010.00235.x     Document Type: Review

References (45)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Available at: (accessed 1 September 2010).
2. Bateman ED, Boushey HA, Bousquet J, etal. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med. 2004;170: 836-44.
3. Bateman ED, Reddel HK, Eriksson G, etal. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol. 2010;125: 600-8.
4. Cazzoletti L, Marcon A, Janson C, etal. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120: 1360-7.
5. Sutherland ER, Martin RJ, Bowler RP, etal. Physiologic correlates of distal lung inflammation in asthma. J Allergy Clin Immunol. 2004;113: 1046-50.
6. Scichilone N, Battaglia S, Olivieri D, Bellia V. The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? Allergy. 2009;64: 1563-9.
7. Menzies D, Nair A, Hopkinson L, etal. Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma. Allergy. 2007;62: 661-7.
8. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross over study in health volunteers. Chest. 2002;122: 510-6.
9. Agertoft L, Laulund LW, Harrison LI, Pedersen S. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children. Pediatr Pulmonol. 2003;35: 192-9.
10. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J. 1998;12: 1346-53.
11. Leach C. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol. 1999;104: S250-2.
12. Leach CL, Bethke TD, Boudreau RJ, etal. Two-dimensional and three-dimensional imaging show ciclosonide had high lung deposition and peripheral distribution: a non-randomized study in healthy volunteers. J Aerosol Med. 2006;19: 117-26.
13. Hamid Q, Song Y, Kotximbos TC, etal. Inflammation of small airways in asthma. J Allergy Clin Immunol. 1997;100: 44-51.
14. Bacsi A, Choudhury BK, Dharajiya N, etal. Subpollen particles: carrier of allergenic proteins and oxidases. J Allergy Clin Immunol. 2006;18: 844-50.
15. Adcock IM, Gilbey T, Gelder CM, etal. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med. 1996;154: 771-82.
16. Wagner EM, Liu MC, Weinmann GG, etal. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis. 1990;148: 584-8.
17. Synek M, Beasley R, Frew AJ, etal. Cellular infiltration of the airways of asthma of varying severity. Am J Respir Crit Care Med. 1996;153: 224-30.
18. Kraft M, Pak J, Martin RJ, etal. Distal lung dysfunction at night in nocturnal asthma. Am J Respir Crit Care Med. 2001;163: 1551-6.
19. Papi A, Paggiaro P, Nicolini G, etal. Beclomethasone/formoterol vs. fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy. 2007;62: 1182-8.
20. Kaminsky DA, Irvin CG, Lundblad L, etal. Oscillation mechanics of the human lung periphery in asthma. J Appl Physiol. 2004;97: 1849-58.
21. Bourdin A, Paganin F, Prefaut C, etal. Nitrogen washout slope in poorly controlled asthma. Allergy. 2006;61: 85-9.
22. Hauber HP, Taha R, Bergeron C, etal. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients. Can Respir J. 2006;13: 73-8.
23. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest. 2007;131: 1353-62.
24. Schichilone N, Battaglia S, Sorino C, etal. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy. 2010;65: 897-902.
25. Verbanck S, Scheuermans D, Vincken W. Inflammation and airway function in the lung periphery of patients with stable asthma. J Allergy Clin Immunol. 2010;125: 611-6.
26. Yamaguchi M, Niimi A, Ueda T, etal. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther. 2009;22: 326-32.
27. Larsen GL, Morgan W, Heldt GP, etal. Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. J Allergy Clin Immunol. 2009;123: 861-7.
28. Downie SR, Salome CM, Verbranck S, etal. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax. 2007;62: 684-9.
29. Ueda T, Niimi A, Matsumoto H, etal. Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol. 2006;118: 1019-25.
30. Samee S, Altes T, Powers P, etal. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol. 2003;111: 1205-11.
31. Busse WW, Brazinsky S, Jacobson K, etal. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol. 1999;104: 1215-22.
32. Thompson PJ, Davies RJ, Young WF, etal. Safety of hydrofluoalkane-134a beclomethasone dipropionate extrafine aerosol. Respir Med. 1998;92: 33-9.
33. Davies RJ, Stampone P, O'Connor BJ. Hydrofluroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir Med. 1998;92: 23-31.
34. van Schayck CP, Donnell D. The efficacy and safety of QVAR (hydrofluoroalkane-beclomethasone dipropionate extrafine aerosol) in asthma (part I): an update of clinical experience in adults. Int J Clin Pract. 2004;58: 678-88.
35. Papi A, Paggiaro PL, Nicolini G, etal. Beclomethasone/formoterol vs. budesonide/formoterol combination therapy in asthma. Eur Respir J. 2007;29: 682-89.
36. Ohbayashi H, Adachi M. Hydrofluoroalkane-Beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study. Allergology International. 2008;57: 1-9.
37. Juniper EF, Price DB, Stampone PA, etal. Clinically important improvements in Asthma-Specific Quality of Life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest. 2002;121: 1824-32.
38. Thongngarm T, Silkoff PE, Kossack WS, Nelson HS. Hydrofluoroalkane-134a beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma. J Asthma. 2005;42: 257-63.
39. Goldin JG, Tashkin DP, Kleerup EC, etal. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thinsection computed tomography. J Allergy Clin Immunol. 1999;104: S258-67.
40. Tunon-de-Lara JM, Laurent F, Giraud V, etal. Air trapping in mild to moderate asthma: Effect of inhaled corticosteroids. J Allergy Clin Immunol. 2007;119: 583-90.
41. Menzies D, Nair A, Hopkinson P, etal. Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma. Allergy. 2007;62: 661-7.
42. Ohbayashi H. One-year evaluation of the preventive effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration. 2007;74: 146-53.
43. Price D, Martin RJ, Barnes N, etal. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol. 2010;126: 511-8.
44. Pauwels RA, Lofdahl CG, Postma DS, etal. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med. 1997;337: 1405-11.
45. Huchon G, Magnussen H, Chuchalin A, etal. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med. 2009;103: 41-9.